Improving efficiency and value in health care - Intravenous iron management for anaemia associated with chronic kidney disease: Linking treatment to an outpatient clinic, optimizing service provision and patient choice

Journal of Evaluation in Clinical Practice

Volumn 14, Issue 6, 2008, Pages 996-1001

  Bhandari, Sunil ^a,b   Naudeer, Sarah ^b  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Anaemia; Chronic kidney disease; CosmoFer; Patient choice; Transport

Indexed keywords

COSMOFER; CREATININE; FERRITIN; HEMOGLOBIN; IRON DEXTRAN; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; IRON THERAPY; KIDNEY FUNCTION; OUTPATIENT CARE; PRIORITY JOURNAL;

AMBULATORY CARE FACILITIES; ANEMIA, IRON-DEFICIENCY; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; EFFICIENCY, ORGANIZATIONAL; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; IRON-DEXTRAN COMPLEX; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE;

EID: 55649095136     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2007.00932.x     Document Type: Article

References (24)

1. Department of Health. (2005) The National Service Framework for Renal Service (Part 2, Chronic Kidney Disease). London : Department of Health.
2. Locatelli, F. (2004) Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrology Dialysis Transplantation, 19 (Suppl. 2 ii1 ii41.
3. Besarab, A., Amin, N., Ahsan, M., Vogel, S. E., Zazuwa, G., Frinak, S., Zazra, J. J., Anandan, J. V. Gupta, A. (2000) Optimization of epoietin therapy with intravenous iron therapy in haemodialysis patients. Journal of the American Society of Nephrology, 11, 530 538.
4. Valderrabano, F., Horl, W. H., Macdougall, I. C., Rossert, J., Rutkowski, B. Wauters, J. P. (2003) Pre-dialysis survey on anaemia management (PRESAM). Nephrology Dialysis Transplantation, 18, 89 100.
5. Bhandari, S., Brownjohn, A. Turney, J. (1998) Effective utilisation of erythropoietin with intravenous iron therapy. Journal of Clinical Pharmacy and Therapeutics, 23 (1 73 78.
6. Bhandari, S., Brownjohn, A. M. Turney, J. H. (1998) Response of mean reticulocyte haemoglobin content to intravenous iron therapy in haemodialysis patients. Nephrology Dialysis Transplantation, 13 (12 3276 3277.
7. Macdougall, I. C., Tucker, B., Thompson, J., Tomson, C. R. V., Baker, L. R. I. Raine, A. E. G. (1996) A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney International, 50, 1694 1699.
8. Peebles, G. Stanley, S. (2004) Evaluation of a service reconfiguration for managing intravenous iron supplementation in non-haemodialysis patients with chronic renal failure. Journal of Outcome Research, 8, 15 25.
9. Bates, D. W., Cullen, D. J., Laird, N., Peterson, L. A., Small, S. D., Servi, D., Laffel, G., Sweitzer, B. S., Shea, B. F. Hallisey, R. (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. Journal of the American Medical Association, 274, 29 34.
10. Dean, B., Schachter, M., Vincent, C. Barber, N. (2002) Prescribing errors in hospital inpatients: their incidence and clinical significance. Quality and Safety in Health Care, 11, 340 344.
11. Wiffen, P., Gill, M., Edwards, J. Moore, A. (2002) Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra. Available at: http://www.jr2.ox.ac.uk/bandolier/ Extraforbando/ADRPM.pdf (last accessed 10 March 2007).
12. Pennell, J. P. (2001) Optimizing medical management of patients with pre-end-stage renal disease. American Journal of Medicine, 111, 559 568.
13. Mohanram, A., Zhang, Z., Shahinfar, S., Keane, W. F., Brenner, B. Toto, R. D. (2004) Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney International, 66, 1131 1138.
14. Bhandari, S., Norfolk, D. R., Brownjohn, A. M. Turney, J. H. (1998) Novel haematological parameters in patients receiving recombinant human Erythropoietin and undergoing haemodialysis. Haematology, 3 (1 67 75.
15. Bhandari, S., Norfolk, D., Brownjohn, A. Turney, J. (1997) Evaluation of red blood cell ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy. American Journal of Kid Disease, 30 (6 814 821.
16. Kallankara, S. Bhandari, S. (2004) What I tell my patients about intravenous iron therapy. British Journal of Renal Medicine, 9 (4 15 18.
17. Hsu, C. Y., McCulloch, C. E. Curhan, G. C. (2002) Epidemiology of anaemia associated with chronic renal insufficiency among adults in the United States: results from the third national health and nutrition examination survey. Journal of the American Society of Nephrology, 13, 504 510.
18. Nice Guidelines. (2006) Anaemia management in people with chronic kidney disease (CKD). Clinical Guidance, CG39.
19. Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M. Reddan, D. (2006) Correction of anaemia with Epoetin Alfa in chronic kidney disease. New England Journal of Medicine, 355, 2085 2098.
20. Drueke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U. Sherhag, A. (2006) CREATE INVESTIGATORS. Normalisation of haemoglobin level in patients with chronic kidney disease and anaemia. New England Journal of Medicine, 355, 2071 2084.
21. Moniem, K. A. Bhandari, S. (2007) Tolerability and efficacy of parenteral iron therapy in haemodialysis patients a comparison of two preparations. Transfusion Alternatives in Transfusion Medicine, 9, 37 42.
22. Vitaline Pharmaceutical UK Ltd. CosmoFer summary of product characteristics April 2001.
23. Auerbach, M., Winchester, J., Wahab, A., Richards, K., McGinley, M., Hall, F., Anderson, J. Briefel, G. (1998) A randomized trial of three iron dextran infusion methods for anaemia in EPO-treated dialysis patients. American Journal of Kidney Diseases, 31, 81 86.
24. Borrill, C. S., Carletta, J., Carter, A. J., Dawson, J. F., Garrod, S., Rees, A., Richards, A., Shapiro, D. West, M. A. (2001) The Effectiveness of Health Care Teams in the National Health Service. Aston Centre for Health Service Organisational Research, University of Aston, Human Communications Research Centre, Universities of Glasgow and Edinburgh, Psychological Therapies Research Centre, University of Leeds.